The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS).

A new drug could change everything for children like seven-year-old Liliana, who has Prader-Willi syndrome, a rare genetic ...

The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS). IPWSO hopes the US FDA approval is the ...

Friends of a popular barber who died last year are raising funds for his two sons. Craig Buxton, aged 50, of Silverdale, ...

Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome ...

Mum-of-five Katie Price isn’t spending Mother’s Day with her children this year—but there’s a reason. The reality TV star, 46 ...

Katie Price has revealed the reason why she’s not spending Mother’s Day with her kids as she told her fans they ‘do all they ...

Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone with FDA approval ...

Sanaa Eddiry embodies excellence and innovation in medical research. With over 15 years of experience, this pioneering ...

US FDA approves Soleno Therapeutics’ Vykat XR to treat hyperphagia in Prader-Willi syndrome: Redwood City, California Saturday, March 29, 2025, 18:00 Hrs [IST] Soleno Therapeuti ...